Diogo, Dorothée
Tian, Chao
Franklin, Christopher S.
Alanne-Kinnunen, Mervi
March, Michael
Spencer, Chris C. A.
Vangjeli, Ciara
Weale, Michael E.
Mattsson, Hannele
Kilpeläinen, Elina
Sleiman, Patrick M. A.
Reilly, Dermot F.
McElwee, Joshua
Maranville, Joseph C.
Chatterjee, Arnaub K.
Bhandari, Aman
Nguyen, Khanh-Dung H.
Estrada, Karol
Reeve, Mary-Pat
Hutz, Janna
Bing, Nan
John, Sally
MacArthur, Daniel G.
Salomaa, Veikko https://orcid.org/0000-0001-7563-5324
Ripatti, Samuli
Hakonarson, Hakon
Daly, Mark J.
Palotie, Aarno
Hinds, David A. https://orcid.org/0000-0002-4911-803X
Donnelly, Peter https://orcid.org/0000-0001-9495-3408
Fox, Caroline S.
Day-Williams, Aaron G.
Plenge, Robert M.
Runz, Heiko
Article History
Received: 27 October 2017
Accepted: 5 September 2018
First Online: 16 October 2018
Competing interests
: D.D. and C.S.F. are employees at Merck Sharp and Dohme. D.F.R., J.M., J.C.M., A.K.C., A.B., A.G.D.W., R.M.P., and H.R. were employees at Merck Sharp and Dohme during the study and are now employed at other companies. C.T. and D.A.H. are employees of 23andMe Inc. C.S.F., C.C.A.S., M.E.W., and P.D. are employees of Genomics plc. C.V. was an employee of Genomics plc during this study. M.R. and J.H. are employees of Eisai. N.B. was an employee of Pfizer during this study. S.J. is an employee at Biogen. K.D.H.N. and K.E. were employees at Biogen during this study and are now employed at other companies. The remaining authors declare no competing interests.